{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/66da48e2d740de0852e81407?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Friday, September 6, 2024","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1725581457941-5b5bf320-a917-49df-a0cc-0a4fc5a1a831.jpeg?height=200","description":"<p>Johnson &amp; Johnson draws the ire of hospitals and the government over a planned change to how it will provide discounts for some of its 340B-eligible drugs. Pfizer becomes the second drug company to get into the direct-to-consumer market.&nbsp;Those stories and more coming up on today’s episode of the Gist Healthcare podcast. </p><p><br></p>","author_name":"Gist Healthcare Daily"}